Clinical Trial - Trial ChiCTR2100050616

Name: Clinical Trial ChiCTR2100050616
Creator: The second Affiliated Hospital of Chongqing Medical University
Keywords: Hashimoto Thyroiditis, Early Phase 1, clinical trial, China

Access comprehensive clinical trial information for ChiCTR2100050616 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by The second Affiliated Hospital of Chongqing Medical University and is currently Recruiting. The study focuses on Hashimoto Thyroiditis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

ChiCTR2100050616

Early Phase 1

Recruiting

Trial Details

Chinese Clinical Trial Registry • ChiCTR2100050616

View on Chinese Clinical Trial Registry

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Untitled Trial

Evaluation of the effects of thyroid function in patients with Hashimoto's thyroiditis after COVID 19 vaccination and study of vaccine safety and efficacy

Study Focus

Disease/Condition

Hashimoto Thyroiditis

Sponsor & Location

Primary Sponsor

The second Affiliated Hospital of Chongqing Medical University

Funder

National Natural Science Foundation of China (Grant No. 81370467)

Location

China

Timeline & Enrollment

Phase

Early Phase 1

Start Date

N/A

End Date

Dec 31, 2022

ICD-10 Classifications

Thyroiditis

Thyroiditis, unspecified

Disorders of thyroid gland

Disorder of thyroid, unspecified

Other disorders of thyroid

Data Source

Registry

Chinese Clinical Trial Registry

Trial ID

ChiCTR2100050616

Type

Non-Device Trial